Investment
Features
FeesSafety
Academy
More
Pluang+

Compare D Wave Quantum Inc (QBTS) vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) (RELX) Price & Performance

D Wave Quantum IncTrade
RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)Trade

Price performance (Past 24H)

Key statistics

D Wave Quantum Inc vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) — how do they compare? D Wave Quantum Inc trades at $11.78 (market cap $5.08B), while RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) trades at $36.73 (market cap $63.57B). The key difference: RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) is far larger — about 12.5× D Wave Quantum Inc's market cap, and RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) pays a 2.49% dividend while D Wave Quantum Inc pays none. Which is the better fit depends on your goals.

QBTSRELX
Market Cap
$5.08B$63.57B
Volume
11,653,3411,602,093
Sector
TechnologyIndustrials
52-Week High
$44.78$46.80
52-Week Low
$12.03$27.73
Typical Hold Time
33 Days—
Enterprise Value
$4.58B$75.05B
Dividend Yield
—2.49%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

D Wave Quantum Inc

QBTS (D-Wave Quantum Inc.) trades at $13.38, down 2.62% on the day, reflecting a bearish technical trend amid negative earnings and high valuation metrics. The company reported a net loss of $355.06M on $24.59M revenue for 2025, with a net income margin of -2,001.59%. Recent news highlights ongoing fraud investigations by multiple law firms, though the company continues to advance its quantum computing technology, such as the launch of a gate-model simulator beta program.

The stock presents a high-risk, speculative opportunity with a unanimous analyst buy rating and a consensus price target of $34.38, implying significant upside. However, substantial financial losses, negative cash flow from operations, and legal uncertainties pose severe risks. Investors should weigh the long-term potential of quantum computing against immediate financial instability and litigation overhangs.

RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)

RELX trades at $36.70, up 0.44% with neutral technical signals. The company demonstrates strong profitability with 23.27% net margins and 132.36% ROE, though valuation metrics appear elevated with P/E of 22.21 and P/B of 38.89. Recent earnings show mixed results with Q2 2026 beating expectations while Q4 2025 missed. Analyst sentiment remains positive with 71% buy ratings and consensus price target of $26.00.

The investment case balances strong fundamentals against premium valuation. Growth catalysts include AI-driven product adoption and margin expansion, while risks involve competitive pressures and valuation concerns. With solid cash flow generation and institutional support, RELX offers quality exposure but requires monitoring of valuation multiples and competitive dynamics.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

QBTS
30% Buy70% Sell
Avg holding period · 33 Days
RELX

No sentiment data available yet.

Top news

Latest headlines on both assets

About D Wave Quantum Inc

D-Wave Quantum Inc. is a global leader in the development and delivery of quantum computing systems, software, and services. The company specializes in annealing quantum computers designed to solve complex optimization problems across industries such as logistics, materials science, and financial modeling. D-Wave offers its technology through the cloud, allowing customers to build and run real-world quantum applications today, making it a key player in the commercialization of quantum computing.

Read more on QBTS →

About RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)

RELX PLC is a UK-based information and analytics company operating across four segments: Risk (fraud prevention and compliance analytics via LexisNexis Risk Solutions), Scientific, Technical & Medical (Elsevier's research and clinical content), Legal (LexisNexis Legal & Professional's research tools), and Exhibitions (RX's trade events). It serves professional, business, and government customers worldwide.

Read more on RELX →